West Pharmaceutical Services (WST)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$4.29 (+1.35%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of West Pharmaceutical Services (WST)
West Pharmaceutical Services is based in Pennsylvania, us, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Key Insights

Critical company metrics and information

  • Share Price

    $322.49

  • Market Cap

    $23.36 Billion

  • Total Outstanding Shares

    72.42 Million Shares

  • Total Employees

    10,600

  • Dividend

    $0.21 Per Share Quarterly

  • IPO Date

    October 27, 1980

  • SIC Description

    Surgical & Medical Instruments & Apparatus

  • Homepage

    https://www.westpharma.com

Historical Stock Splits

If you bought 1 share of WST before September 27, 2013, you'd have 2 shares today.
Execution DateSplit Amount
September 27, 20132-for-1

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Financing Activities, Continuing$-743.20 Million
Net Cash Flow From Investing Activities, Continuing$-382.70 Million
Net Cash Flow, Continuing$-423.50 Million
Net Cash Flow From Operating Activities, Continuing$702.40 Million
Net Cash Flow From Operating Activities$702.40 Million
Net Cash Flow From Financing Activities$-743.20 Million
Net Cash Flow From Investing Activities$-382.70 Million
Net Cash Flow$-419.10 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Revenues$2.88 Billion
Benefits Costs and Expenses$2.29 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Income Tax Expense/Benefit$105.20 Million
Research and Development$69.00 Million
Income/Loss From Continuing Operations After Tax$483.60 Million
Net Income/Loss Available To Common Stockholders, Basic$499.60 Million
Operating Expenses$431.90 Million
Income/Loss Before Equity Method Investments$588.80 Million
Income/Loss From Equity Method Investments$16.00 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Interest Expense, Operating$5.00 Million
Income/Loss From Continuing Operations Before Tax$588.80 Million
Other Operating Expenses$19.70 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Nonoperating Income/Loss$17.60 Million
Costs And Expenses$2.29 Billion
Net Income/Loss$499.60 Million
Cost Of Revenue$1.87 Billion
Gross Profit$1.00 Billion
Selling, General, and Administrative Expenses$343.20 Million
Basic Earnings Per Share$6.81
Basic Average Shares$73.00 Million
Operating Income/Loss$571.20 Million
Net Income/Loss Attributable To Parent$499.60 Million
Diluted Earnings Per Share$6.74
Diluted Average Shares$73.60 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Inventory$401.20 Million
Other Non-current Assets$541.20 Million
Other Non-current Liabilities$203.90 Million
Equity$2.75 Billion
Fixed Assets$1.57 Billion
Accounts Payable$224.30 Million
Liabilities$923.00 Million
Current Liabilities$516.50 Million
Equity Attributable To Parent$2.75 Billion
Equity Attributable To Noncontrolling Interest$0.00
Long-term Debt$202.60 Million
Noncurrent Liabilities$406.50 Million
Liabilities And Equity$3.68 Billion
Noncurrent Assets$2.12 Billion
Current Assets$1.55 Billion
Intangible Assets$12.30 Million
Other Current Liabilities$292.20 Million
Other Current Assets$1.15 Billion
Assets$3.68 Billion

Historical Dividends

Current dividend: $0.21 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Oct 24, 2024Nov 20, 2024Nov 13, 2024$0.21Quarterly
Apr 25, 2024Aug 7, 2024Jul 31, 2024$0.2Quarterly
Feb 20, 2024May 1, 2024Apr 24, 2024$0.2Quarterly
Dec 6, 2023Feb 7, 2024Jan 31, 2024$0.2Quarterly
Oct 26, 2023Nov 15, 2023Nov 8, 2023$0.2Quarterly
Apr 27, 2023Aug 2, 2023Jul 26, 2023$0.19Quarterly
Mar 3, 2023May 3, 2023Apr 26, 2023$0.19Quarterly
Dec 13, 2022Feb 1, 2023Jan 25, 2023$0.19Quarterly
Oct 27, 2022Nov 16, 2022Nov 9, 2022$0.19Quarterly
Apr 28, 2022Aug 3, 2022Jul 20, 2022$0.18Quarterly
Feb 23, 2022May 4, 2022Apr 20, 2022$0.18Quarterly
Jan 5, 2022Feb 2, 2022Jan 19, 2022$0.18Quarterly
May 5, 2021Aug 4, 2021Jul 21, 2021$0.17Quarterly
Feb 24, 2021May 5, 2021Apr 21, 2021$0.17Quarterly
Dec 9, 2020Feb 3, 2021Jan 20, 2021$0.17Quarterly
Oct 28, 2020Nov 18, 2020Nov 11, 2020$0.17Quarterly
Jul 15, 2020Aug 5, 2020Jul 29, 2020$0.16Quarterly
Feb 25, 2020May 6, 2020Apr 22, 2020$0.16Quarterly
Dec 13, 2019Feb 5, 2020Jan 22, 2020$0.16Quarterly
Jul 25, 2019Nov 6, 2019Oct 23, 2019$0.16Quarterly
May 8, 2019Aug 7, 2019Jul 24, 2019$0.15Quarterly
Feb 21, 2019May 1, 2019Apr 17, 2019$0.15Quarterly
Dec 18, 2018Feb 6, 2019Jan 23, 2019$0.15Quarterly
May 3, 2018Nov 7, 2018Oct 24, 2018$0.15Quarterly
May 3, 2018Aug 1, 2018Jul 18, 2018$0.14Quarterly
Feb 15, 2018May 2, 2018Apr 18, 2018$0.14Quarterly
Jul 20, 2017Nov 1, 2017Oct 18, 2017$0.14Quarterly
May 15, 2017Aug 2, 2017Jul 19, 2017$0.13Quarterly
Feb 16, 2017May 3, 2017Apr 19, 2017$0.13Quarterly
Dec 14, 2016Feb 1, 2017Jan 18, 2017$0.13Quarterly
Sep 12, 2016Nov 2, 2016Oct 19, 2016$0.13Quarterly
Jul 5, 2016Aug 3, 2016Jul 20, 2016$0.12Quarterly
Mar 4, 2016May 4, 2016Apr 20, 2016$0.12Quarterly
Dec 17, 2015Feb 3, 2016Jan 20, 2016$0.12Quarterly
Jul 14, 2015Nov 4, 2015Oct 21, 2015$0.12Quarterly
Jul 1, 2015Aug 5, 2015Jul 22, 2015$0.11Quarterly
Feb 20, 2015May 6, 2015Apr 22, 2015$0.11Quarterly
Dec 16, 2014Feb 4, 2015Jan 21, 2015$0.11Quarterly
Jul 15, 2014Nov 5, 2014Oct 22, 2014$0.11Quarterly
May 6, 2014Aug 6, 2014Jul 23, 2014$0.1Quarterly
Feb 20, 2014May 7, 2014Apr 23, 2014$0.1Quarterly
Dec 19, 2013Feb 5, 2014Jan 22, 2014$0.1Quarterly
Aug 1, 2013Nov 6, 2013Oct 23, 2013$0.1Quarterly
May 10, 2013Aug 7, 2013Jul 24, 2013$0.19Quarterly
Feb 19, 2013May 1, 2013Apr 17, 2013$0.19Quarterly
Dec 27, 2012Feb 6, 2013Jan 23, 2013$0.19Quarterly
Oct 1, 2012Nov 7, 2012Oct 24, 2012$0.19Quarterly

Related Companies

View additional S&P 500 companies similar to West Pharmaceutical Services (WST)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

â“’ 2024 Financhle. All Rights Reserved.